A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)

Researchers are looking for new treatments for people living with HIV‐1 (HumanImmunodeficiency Virus Type 1). HIV‐1 is the most common type of HIV, which is a virusthat attacks cells of the immune system.MK‐4646 is a trial medicine designed to treat HIV‐1. Before giving a trial medicine topeople with a health condition, researchers first do studies in healthy participants.The goals of this trial are to learn: ‐ What happens to rosuvastatin in a participant's body over time when it is taken withMK‐4646 ‐ About the safety of MK‐4646 when taken with rosuvastatin and if people tolerate it.Tolerate means participants will receive trial medicine in the trial unless theyneed to stop it due to health problems.